immunization avian h5 influenza hemagglutinin mutants altered receptor binding specificity 
influenza virus entry mediated receptor binding domain rbd spike hemagglutinin ha adaptation avian viruses humans associated ha specificity alpha rather alpha -linked sialic acid sa receptors define mutations influenza subtype h5n1 avian ha alter specificity sa either decreasing alpha increasing alpha sa recognition rbd mutants used develop vaccines monoclonal antibodies neutralized new variants structure-based modification ha specificity can guide development preemptive vaccines therapeutic monoclonal antibodies can evaluated emergence human-adapted h5n1 strains 
